suPAR: the molecular crystal ball - PubMed (original) (raw)
Review
suPAR: the molecular crystal ball
Maria Thunø et al. Dis Markers. 2009.
Abstract
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in three forms; suPAR(I-III), suPAR(II-III) and suPAR(I) which show different properties due to structural differences. Studies suggest that full-length suPAR is a regulator of uPAR/uPA by actingas uPA-scavenger, whereas the cleaved suPAR(II-III) act as a chemotactic agent promoting the immune response via the SRSRY sequence in the linker-region. This review focus on the various suPAR fragments and their involvement in inflammation and pathogenic processes. We focus on the molecular mechanisms of the suPAR fragments and the link to the inflammatory process,as this could lead to medical applications in infectious and pathological conditions.
Similar articles
- The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers.
Ahmad A, Saha P, Evans C, Thurison T, Hoyer-Hansen G, Patel A, Modarai B, Smith A. Ahmad A, et al. J Vasc Surg Venous Lymphat Disord. 2015 Apr;3(2):190-7. doi: 10.1016/j.jvsv.2014.08.002. Epub 2014 Nov 1. J Vasc Surg Venous Lymphat Disord. 2015. PMID: 26993839 - Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.
Selleri C, Montuori N, Salvati A, Serio B, Pesapane A, Ricci P, Gorrasi A, Li Santi A, Hoyer-Hansen G, Ragno P. Selleri C, et al. Oncotarget. 2016 Sep 13;7(37):60206-60217. doi: 10.18632/oncotarget.11115. Oncotarget. 2016. PMID: 27517491 Free PMC article. - COVID-19 and pneumonia: a role for the uPA/uPAR system.
D'Alonzo D, De Fenza M, Pavone V. D'Alonzo D, et al. Drug Discov Today. 2020 Aug;25(8):1528-1534. doi: 10.1016/j.drudis.2020.06.013. Epub 2020 Jun 18. Drug Discov Today. 2020. PMID: 32562843 Free PMC article. Review. - uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy.
Lund IK, Illemann M, Thurison T, Christensen IJ, Høyer-Hansen G. Lund IK, et al. Curr Drug Targets. 2011 Nov;12(12):1744-60. doi: 10.2174/138945011797635902. Curr Drug Targets. 2011. PMID: 21707477 Review.
Cited by
- Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG, de Beer FM, Tuip-de Boer AM, van der Poll T, Horn J, Cremer OL, Bonten MJ, Ong DS, Schultz MJ, Bos LD. Geboers DG, et al. Intensive Care Med. 2015 Jul;41(7):1281-90. doi: 10.1007/s00134-015-3924-9. Epub 2015 Jun 23. Intensive Care Med. 2015. PMID: 26100127 - Urinary biomarkers associated with podocyte injury in lupus nephritis.
Guo Z, Guo Q, Li X, Gao X, Zhang L, Xu K. Guo Z, et al. Front Pharmacol. 2024 Jan 19;15:1324540. doi: 10.3389/fphar.2024.1324540. eCollection 2024. Front Pharmacol. 2024. PMID: 38313309 Free PMC article. Review. - Serum Calprotectin, a Marker of Neutrophil Activation, and Other Mediators of Inflammation in Response to Various Types of Extreme Physical Exertion in Healthy Volunteers.
Niemelä M, Niemelä O, Bloigu R, Bloigu A, Kangastupa P, Juvonen T. Niemelä M, et al. J Inflamm Res. 2020 May 22;13:223-231. doi: 10.2147/JIR.S250675. eCollection 2020. J Inflamm Res. 2020. PMID: 32547154 Free PMC article. - Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease.
Ismail A, Hayek SS. Ismail A, et al. Curr Cardiol Rep. 2023 Dec;25(12):1797-1810. doi: 10.1007/s11886-023-01991-7. Epub 2023 Nov 10. Curr Cardiol Rep. 2023. PMID: 37948017 Review. - Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.
Uzawa A, Kojima Y, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Kuwabara S. Uzawa A, et al. Clin Exp Immunol. 2020 Dec;202(3):321-324. doi: 10.1111/cei.13499. Epub 2020 Aug 10. Clin Exp Immunol. 2020. PMID: 32706905 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous